NXS
Click for more information
0.00% 22.5¢ next science limited

Non-sponsored medical literature? I can't comment on the quality...

  1. SoundsSnazzy
    24 Posts.
    lightbulb Created with Sketch. 10
    clock Created with Sketch.
    06/05/19
    19:23
    Post #: 38434934
    Non-sponsored medical literature?

    I can't comment on the quality of evidence or possible bias of the research but it's worth noting that the founder and CTO, with a share holding of almost $50M at today's valuation, is the lead or contributing author on almost all studies involving the technology.
    NXS Price at posting: $2.40 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
22.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $65.63M
Open High Low Value Volume
22.0¢ 22.5¢ 22.0¢ $25.06K 113.0K

Buyers (Bids)

No. Vol. Price($)
1 1979 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 2441 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.